The SURMOUNT-1 trial (*NEJM*, 2022) showed participants on 15mg Tirzepatide lost an average of 22.5% of their body weight at 72 weeks -- roughly 5 percentage points more than Semaglutide achieves
doi: 10.2337/dc08-1755 62 KooD-HHanK-DParkC-Y
Key Takeaways Wolverine Stack usually means BPC-157 plus TB-500
Related Reading Injection Wegovy Injection Tirzepatide Injection Semaglutide Injection Ozempic Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
BPC-157 protects tissue and promotes angiogenesis
Your GP can assess whether the benefits of Ozempic outweigh the side effects in your individual case and may consider: Adjusting the dose or titration schedule Investigating other potential causes of bloating (such as small intestinal bacterial overgrowth, coeliac disease, or irritable bowel syndrome) Referring to a gastroenterologist if symptoms are atypical or severe Considering alternative diabetes medications if Ozempic is not well-tolerated Patient safety is paramount, and open communication with healthcare providers ensures that any concerning symptoms are appropriately evaluated whilst maintaining effective diabetes management
